Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry
Journal of Gynecologic Oncology · 2025 · 36 (3)
DOI: 10.3802/jgo.2025.36.e41 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Kensuke Sakai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Peritoneum. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: The prognostic value and clinical usage of peritoneal cytology in endometrial cancer are uncertain. This study aimed to determine whether positive cytology is associated with the prognosis for endometrial cancer. METHODS: A Japanese nationwide retrospective registry study was conducted between 2012 and 2019. Clinicopathological data were analyzed for patients who were registered in the Japan Society of Obstetrics and Gynecology (JSOG) gynecological tumor registry and underwent initial treatment for endometrial cancer. RESULTS: In total, 83,027 patients who met the inclusion criteria were identified. Data on peritoneal cytology status and overall survival (OS) were available for 74,984 and 36,995 patients, respectively. Positive peritoneal cytology was found in 11,536 (15.4%) patients. A higher proportion of patients who had positive peritoneal cytology were related to advanced stages, high-grade histology, deep myometrial invasion, lymph node (LN) metastasis, and poor risk of recurrence. After controlling for age, stage, myometrial invasion, LN metastasis, distant metastasis, and risk of recurrence, positive peritoneal cytology was associated with poor prognosis (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. gami@z8.keio.jp.
- Department of Information Science, Iwate Medical University, Iwate, Japan.
- Department of Gynecology, Tohoku University Hospital, Miyagi, Japan.
- Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Aomori, Japan.
ORCID-Profile: Kensuke Sakai, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Zitieren
APA
Sakai, K., Yamagami, W., Takahashi, F., Tokunaga, H., Yamamoto, E., Yokoyama, Y., Yoshino, K., Kawana, K., & Nagase, S. (2025). Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry. Journal of Gynecologic Oncology, 36(3). https://doi.org/10.3802/jgo.2025.36.e41
Vancouver
Sakai K, Yamagami W, Takahashi F, Tokunaga H, Yamamoto E, Yokoyama Y, et al. Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry. Journal of Gynecologic Oncology. 2025;36(3). doi:10.3802/jgo.2025.36.e41
BibTeX
@article{Sakai2025,
author = {Sakai, Kensuke and Yamagami, Wataru and Takahashi, Fumiaki and Tokunaga, Hideki and Yamamoto, Eiko and Yokoyama, Yoshihito and Yoshino, Kiyoshi and Kawana, Kei and Nagase, Satoru},
title = {Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry},
journal = {Journal of Gynecologic Oncology},
year = {2025},
volume = {36},
number = {3},
doi = {10.3802/jgo.2025.36.e41}
}
EUVIMED